Pages that link to "Q74340210"

The following pages link to Functional co-expression of CYP2D6 and human NADPHcytochrome P450 reductase in Escherichia coli (Q74340210):

Displaying 23 items.

• The P450 CYP6Z1 confers carbamate/pyrethroid cross-resistance in a major African malaria vector beside a novel carbamate-insensitive N485I acetylcholinesterase-1 mutation (Q26314467) (← links)
• Human NADPH-P450 oxidoreductase modulates the level of cytochrome P450 CYP2D6 holoprotein via haem oxygenase-dependent and -independent pathways (Q28365626) (← links)
• NADPH-cytochrome P450 reductase: molecular cloning and functional characterization of two paralogs from Withania somnifera (L.) dunal (Q28486400) (← links)
• Merits and limitations of recombinant models for the study of human P450-mediated drug metabolism and toxicity: an intralaboratory comparison. (Q33639797) (← links)
• Cutaneous expression of cytochrome P450 CYP2S1: individuality in regulation by therapeutic agents for psoriasis and other skin diseases. (Q34192436) (← links)
• Pinpointing P450s associated with pyrethroid metabolism in the dengue vector, Aedes aegypti: developing new tools to combat insecticide resistance (Q34222763) (← links)
• The highly polymorphic CYP6M7 cytochrome P450 gene partners with the directionally selected CYP6P9a and CYP6P9b genes to expand the pyrethroid resistance front in the malaria vector Anopheles funestus in Africa (Q34316704) (← links)
• Update information on human P450s (Q34627922) (← links)
• A role for cytochrome b5 in the In vivo disposition of anticancer and cytochrome P450 probe drugs in mice (Q37604428) (← links)
• Resistance irrelevant CYP417A2v2 was found degrading insecticide in Laodelphax striatellus. (Q38695838) (← links)
• Genome-Wide Transcription and Functional Analyses Reveal Heterogeneous Molecular Mechanisms Driving Pyrethroids Resistance in the Major Malaria Vector Anopheles funestus Across Africa (Q38850502) (← links)
• Predicting drug clearance from recombinantly expressed CYPs: intersystem extrapolation factors (Q40529215) (← links)
• Use of transgenic cell lines in mechanistic studies of drug metabolism (Q40803367) (← links)
• Defining the in Vivo Role for cytochrome b5 in cytochrome P450 function through the conditional hepatic deletion of microsomal cytochrome b5. (Q41824446) (← links)
• Phe120 contributes to the regiospecificity of cytochrome P450 2D6: mutation leads to the formation of a novel dextromethorphan metabolite. (Q42103895) (← links)
• In vitro effects of active constituents and extracts of Orthosiphon stamineus on the activities of three major human cDNA-expressed cytochrome P450 enzymes (Q42753981) (← links)
• Role of conserved Asp293 of cytochrome P450 2C9 in substrate recognition and catalytic activity. (Q43002752) (← links)
• Residues glutamate 216 and aspartate 301 are key determinants of substrate specificity and product regioselectivity in cytochrome P450 2D6. (Q44226094) (← links)
• Purification and characterization of a soluble form of rat liver NADPH-cytochrome P-450 reductase highly expressed in Escherichia coli (Q44428699) (← links)
• Optimizing bacterial expression of catalytically active human cytochromes P450: comparison of CYP2C8 and CYP2C9. (Q44741178) (← links)
• Mutagenesis testing based on bacterial expression of human P450s (Q50106661) (← links)
• Heterologous Expression of Human Cytochromes P450 2D6 and CYP3A4 in Escherichia coli and Their Functional Characterization (Q55055040) (← links)
• Layer-by-Layer Assembly of Nanosized Membrane Fractions for the Assessment of Cytochrome P450 Xenobiotic Metabolism (Q92931436) (← links)